BERNENGO, Maria Grazia

BERNENGO, Maria Grazia  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 331 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 2012 Simone Ribero; Pietro Quaglino; Martina Sanlorenzo; Simona Osella-Abate; Federica Marenco; Tiziana Nardò; Giuseppe Macripò; Maria Teresa Fierro; Maria Grazia Bernengo
A case of acute promyelocytic leukaemia with bullous, haemorrhagic and necrotic skin lesions. 1975 BERNENGO MG ;LEIGHEB G ;ZINA G
Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study. 1994 CASCINELLI N; FOA R; PARMIANI G; ARIENTI F; BELLI F; BERNENGO M; CLEMENTE C; COLOMBO MP; GUARINI A; ILLENI MT
Active rosette test in cutaneous lymphoproliferative disorders. 1977 BERNENGO MG ;CAPELLA G ;MASCOLI I ;ZINA G
Activity and safety of bexarotene as maintainance therapy in advanced/aggressive CTCL patients with stable disease or remission after systemic treatment: an observational multicenter trial from the GILC 2007 Pietro Quaglino; Maria Grazia Bernengo
Activity and safety of Bexarotene as maintenance therapy in CTCL patients (Mycosis Fungoides stage IIB-IV, Sezary Syndrome, peripheral T-cell lymphoma) with stable disease or remission after systemic treatments: A prospective multicenter trauil from the Italian Group of Cutaneous Lymphoma (GILC) 2011 Quaglino P;Pimpinelli N; Alaibac M; Quintini G; Bernengo MG
[Activity of deoxycytidylate-deaminase in human lymphocytes stimulated with phytohemagglutinin] 1970 BERNENGO MG ;BENZIO G ;CISIANO L ;PEGORARO L
Adhesion molecules in lymphomatoid granulomatosis 1994 SAVOIA P; M. NOVELLI; BERTERO M; BERNENGO MG
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance 1995 DOVEIL GC; FIERRO MT; M. NOVELLI; APPINO A; BERTERO M; QUAGLINO P; BERNENGO MG
Adult-onset cutaneous mastocytosis in monozygotic twins. 2011 Quaglino P; Mola F; Peroni A; Ortoncelli M; Di Bello C; Savoia P; Bernengo MG
After Surgery: Follow-Up Guidelines of Melanoma Patients 2013 Paolo Fava; Pietro Quaglino; Maria Grazia Bernengo; Paola Savoia
Aggressive subtypes of cutaneous T-cell lymphoma subsets: management and prognosis. 2003 BERNENGO M.G.; QUAGLINO P.
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 2006 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT.
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 2011 Banche G; Allizond V; Novelli M; Fierro MT; Mandras N; Murabito P; Quaglino P; Scalas D; Merlino C; Roana J; Tullio V; Bernengo MG; Cuffini AM
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 2009 G. Banche; M.T. Fierro; M. Novelli; V. Allizond; A. Comessatti; P. Quaglino; D. Scalas; C. Merlino; M.G. Bernengo; A Cuffini
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 1996 Fierro MT; Verrone A; Savoia P; Quaglino P; Doveil GC; Bernengo MG
Atopic dermatitis in a phenylketonuric untreated patient 2015 Fava p; Fierro MT; Brizio M; Marra E; Spada M; Bernengo MG
Attività clinica e modulazione immunologica di bexarotene a basse dosi: presentazione di un caso 2008 Quaglino Pietro; Marenco Federica; Fava Paolo; Bernengo Maria Grazia
BANS: a discussion of the problem. 1992 BERNENGO MG ;REALI UM ;DOVEIL GC ;CAPPELLO N ;LISA F ;MORETTI S
Biological prognostic factors in advanced metastatic melanoma patients treated with chemoimmunotheraphy. 1997 Fierro MT; Quaglino P; Lisa F; Savoia P; Bernengo MG